OPKO Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of OPKO Health generated cash of -$28,197,000, which is more than the previous year. Cash used in financing activities reached the amount of -$11,303,000 last year. Net change in cash is therefore -$57,310,000.
Cash Flow
| 2014 | -90.37M | -5.67M | 7.26M |
|---|---|---|---|
| 2015 | 164.02M | -99.22M | 33.00M |
| 2016 | 32.04M | -20.70M | -35.19M |
| 2017 | -92.08M | -46.66M | 61.04M |
| 2018 | -109.14M | -26.11M | 140.90M |
| 2019 | -172.52M | -13.27M | 175.24M |
| 2020 | 39.47M | -18.32M | -35.07M |
| 2021 | 38.33M | 35.94M | -10.35M |
| 2022 | -95.18M | 91.03M | 22.97M |
| 2023 | -28.19M | -18.19M | -11.30M |
OPK Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 153.19M | 134.71M | 72.21M | 85.45M | 96.47M | 91.49M | 168.73M | 193.59M | 96.90M | 185.79M |
Operating activities | ||||||||||
Net income | -188.86M | -328.40M | -30.14M | 30.58M | -314.92M | -153.04M | -305.25M | -25.08M | -31.42M | -174.63M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 105.29M | 108.65M | 78.71M | 85.36M | 93.80M | 97.34M | 102.09M | 96.57M | 42.24M | 14.92M |
Stock-based compensation expense | 11.41M | 18.50M | 13.63M | 8.94M | 13.42M | 0 | 28.30M | 42.69M | 26.07M | 14.77M |
| Deferred income tax benefit | 11.41M | 18.50M | 13.63M | 8.94M | 13.42M | 0 | 28.30M | 42.69M | 26.07M | 14.77M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 3.41M | 128.60M | 5.23M | -150.43M | 7.37M | 20.39M | 58.01M | -25.63M | -29.39M | -3.91M |
Inventories | 15.19M | 13.66M | 30.68M | -77.64M | -12.13M | 4.59M | -3.53M | -6.60M | -5.87M | -1.75M |
Accounts payable | 2.82M | -9.38M | -10.84M | 37.15M | 15.63M | -26.08M | 20.17M | -19.81M | -18.12M | -3.85M |
Cash generated by operating activities | -28.19M | -95.18M | 38.33M | 39.47M | -172.52M | -109.14M | -92.08M | 32.04M | 164.02M | -90.37M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 32.15M | -245K | -1.2M | 27.85M | 46.52M | -15.64M | -4.37M | 4.73M |
Investments In Property Plant And Equipment | -16.27M | -24.57M | -32.15M | -33.68M | -12.74M | -27.85M | -46.52M | -23.54M | -15.84M | -4.73M |
Acquisitions Net | 0 | -1.75M | -6M | 245K | -1.2M | -1M | -9.62M | 1.45M | -83.37M | -2.27M |
Cash generated by investing activities | -18.19M | 91.03M | 35.94M | -18.32M | -13.27M | -26.11M | -46.66M | -20.70M | -99.22M | -5.67M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 221.66M | 1.08M | 756K | 76.06M | 92.5M | 2.13M | 4.85M | 25.92M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -272K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -11.03M | 23.74M | -1.69B | -1.14B | 106.95M | -34.68M | 58.91M | -66.17M | 6.98M | -28.36M |
Cash used in financing activities | -11.30M | 22.97M | -10.35M | -35.07M | 175.24M | 140.90M | 61.04M | -35.19M | 33.00M | 7.26M |
Net Change In Cash | -57.31M | 18.48M | 62.49M | -13.24M | -11.02M | 4.97M | -77.23M | -24.86M | 96.69M | -88.89M |
Cash at end of period | 95.88M | 153.19M | 134.71M | 72.21M | 85.45M | 96.47M | 91.49M | 168.73M | 193.59M | 96.90M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |